JP2002510643A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002510643A5 JP2002510643A5 JP2000542029A JP2000542029A JP2002510643A5 JP 2002510643 A5 JP2002510643 A5 JP 2002510643A5 JP 2000542029 A JP2000542029 A JP 2000542029A JP 2000542029 A JP2000542029 A JP 2000542029A JP 2002510643 A5 JP2002510643 A5 JP 2002510643A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- medicament
- cd40cr
- therapeutic treatment
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5448898A | 1998-04-03 | 1998-04-03 | |
| US09/054,488 | 1998-04-03 | ||
| PCT/US1999/007321 WO1999051258A1 (en) | 1998-04-03 | 1999-04-02 | USE OF ANTI-gp39 ANTIBODIES FOR TREATMENT AND/OR REVERSAL OF LUPUS AND ASSOCIATED KIDNEY DISEASE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002510643A JP2002510643A (ja) | 2002-04-09 |
| JP2002510643A5 true JP2002510643A5 (OSRAM) | 2006-05-11 |
Family
ID=21991433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000542029A Withdrawn JP2002510643A (ja) | 1998-04-03 | 1999-04-02 | 狼瘡およびその関連腎臓疾患の治療および／または後退のための抗−ｇｐ３９抗体の使用 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1067954A4 (OSRAM) |
| JP (1) | JP2002510643A (OSRAM) |
| KR (1) | KR20010072564A (OSRAM) |
| CN (2) | CN100352497C (OSRAM) |
| AU (1) | AU743824B2 (OSRAM) |
| HU (1) | HUP0101689A3 (OSRAM) |
| NO (1) | NO20004966L (OSRAM) |
| TW (1) | TWI224969B (OSRAM) |
| WO (1) | WO1999051258A1 (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA41459A (fr) | 2015-02-03 | 2017-12-12 | Als Therapy Development Inst | Anticorps anti-cd40l et méthodes pour traiter des maladies ou des troubles liés aux cd40l |
| EA201890434A1 (ru) | 2015-08-05 | 2018-10-31 | Янссен Байотек, Инк. | Антитела к cd154 и способы их применения |
| SG10202111207TA (en) | 2017-05-24 | 2021-11-29 | Als Therapy Development Inst | Therapeutic anti-cd40 ligand antibodies |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5672347A (en) * | 1984-07-05 | 1997-09-30 | Genentech, Inc. | Tumor necrosis factor antagonists and their use |
| US5474771A (en) * | 1991-11-15 | 1995-12-12 | The Trustees Of Columbia University In The City Of New York | Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same |
| IL104684A0 (en) * | 1992-02-14 | 1993-06-10 | Bristol Myers Squibb Co | The cd40cr receptor and ligands therefor |
| US5876950A (en) * | 1995-01-26 | 1999-03-02 | Bristol-Myers Squibb Company | Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy |
| US5833987A (en) * | 1995-06-07 | 1998-11-10 | Trustees Of Dartmouth College | Treatment of T cell mediated autoimmune disorders |
| US6001358A (en) * | 1995-11-07 | 1999-12-14 | Idec Pharmaceuticals Corporation | Humanized antibodies to human gp39, compositions containing thereof |
| NZ337072A (en) * | 1997-01-10 | 2000-12-22 | Biogen Inc | use of an anti-CD40L compounds to inhibit the progression of nephritis, stabilize nephritis or reverse nephritis in a patient with an immune complex disease |
| AU5623398A (en) * | 1997-03-07 | 1998-09-22 | Biogen, Inc. | Methods of therapeutic administration of anti-cd40l compounds |
| WO1999000143A1 (en) * | 1997-06-27 | 1999-01-07 | Biogen, Inc. | Cd154 blockade therapy for autoimmune diseases |
-
1999
- 1999-04-02 HU HU0101689A patent/HUP0101689A3/hu unknown
- 1999-04-02 WO PCT/US1999/007321 patent/WO1999051258A1/en not_active Ceased
- 1999-04-02 KR KR1020007011045A patent/KR20010072564A/ko not_active Ceased
- 1999-04-02 CN CNB200410078988XA patent/CN100352497C/zh not_active Expired - Fee Related
- 1999-04-02 AU AU33796/99A patent/AU743824B2/en not_active Withdrawn - After Issue
- 1999-04-02 JP JP2000542029A patent/JP2002510643A/ja not_active Withdrawn
- 1999-04-02 EP EP99915237A patent/EP1067954A4/en not_active Withdrawn
- 1999-04-02 CN CNB998067563A patent/CN1173735C/zh not_active Expired - Fee Related
- 1999-06-28 TW TW088105322A patent/TWI224969B/zh not_active IP Right Cessation
-
2000
- 2000-10-02 NO NO20004966A patent/NO20004966L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003507013A5 (OSRAM) | ||
| JP2003503454A5 (OSRAM) | ||
| WO2004110472A3 (en) | Fusion proteins | |
| JP2003520232A5 (OSRAM) | ||
| EP1941904A3 (en) | Anti-TNF antibodies and methotrexate in the treatment of autoimmune diseases | |
| WO2005061545A3 (en) | Nogoa antibodies for the treatment of alzheimer disease | |
| ZA975866B (en) | Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases. | |
| EP1357131A3 (en) | Treatment of lupus nephritis with anti-CD4OL compounds | |
| AU2001264042A1 (en) | 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof | |
| AU2002212471A1 (en) | Peptides for use in the treatment of alzheimer's disease | |
| DK1643999T3 (da) | Pyridoxamin til anvendelse ved behandlingen af diabetisk nefropati ved type 2-diabetes | |
| AU2001232275A1 (en) | Novel collagen-like protein clac, precursor thereof and genes encoding the same | |
| WO2001083688A3 (en) | A novel polypeptide, a human subunit 13 phosphatidylinositol-4-phosphate-5-kinase ii beta and the polynucleotide encoding the polypeptide | |
| JP2003522147A5 (OSRAM) | ||
| JPH1017388A5 (OSRAM) | ||
| WO2002022819A3 (en) | Calcium binding proteins | |
| JP2003501387A5 (OSRAM) | ||
| JP2002536413A5 (OSRAM) | ||
| JP2001294524A5 (OSRAM) | ||
| JP2003525251A5 (OSRAM) | ||
| JP2000214163A5 (OSRAM) | ||
| JPH1025251A5 (OSRAM) | ||
| RU2000105081A (ru) | Применение препарата "эсвицин" для лечения ревматоидного артрита | |
| AU2001267826A1 (en) | Remedies for alzheimer's disease | |
| EZZELL | Africa's Suffering. |